---
reference_id: "DOI:10.3390/dermatopathology11030024"
title: Interleukin-36 Is Highly Expressed in Skin Biopsies from Two Patients with Netherton Syndrome
authors:
- Johannes Pawlowski
- Tatsiana Pukhalskaya
- Kelly Cordoro
- Marina Kristy Ibraheim
- Jeffrey P. North
journal: Dermatopathology
year: '2024'
doi: 10.3390/dermatopathology11030024
content_type: abstract_only
---

# Interleukin-36 Is Highly Expressed in Skin Biopsies from Two Patients with Netherton Syndrome
**Authors:** Johannes Pawlowski, Tatsiana Pukhalskaya, Kelly Cordoro, Marina Kristy Ibraheim, Jeffrey P. North
**Journal:** Dermatopathology (2024)
**DOI:** [10.3390/dermatopathology11030024](https://doi.org/10.3390/dermatopathology11030024)

## Content

Netherton syndrome (NS) is a rare autosomal recessive disorder that occurs due to a loss-of-function mutation in SPINK5; this loss results in significant inflammation, as well as perturbations of the skin barrierâ€™s integrity and functionality. While it is unclear which inflammatory pathways contribute to the development of NS, recent studies have demonstrated the expression of interleukin (IL)-17/IL-36, as well as several Th2 cytokines. Consequently, immunohistochemistry (IHC) with IL-36 may serve as a potential tool for aiding the histopathological diagnosis of this condition. In this case series, we present two cases of NS and capture their immunostaining pattern with IL-36. Both cases demonstrated robust expression of IL-36. This finding bolsters the hypothesis that NS is partially driven by Th17 activation and suggests the potential utility of IL-36 IHC as part of the workup for this rare and diagnostically elusive entity. LEKTI IHC was negative in one biopsy, revealing a limitation of this stain in diagnosing NS.